Parasite | Eso | Sto | Cancer | ESD
[Gastric cancer 804. ESD for cardia cancer in the remnant stomach - pathologically non-curative resection]
001 | 101 | 201 | 301 | 401 | 501 | 601 | 701 | 801 | 901 | 1000
ESD for a cardia cancer in the remnant stomach (female 75) was done. Because of the location, the procedure was difficult but successful. However, the pathology was non-curative resection. How would you recommend?
ESD: Early gastric carcinoma
1. Location : cardia
2. Gross type : EGC type IIb
3. Histologic type : tubular adenocarcinoma, moderately differentiated
4. Histologic type by Lauren : intestinal
5. Size of carcinoma : (1) longest diameter, 20 mm (2) vertical diameter, 12 mm
6. Depth of invasion : invades submucosa, (depth of sm invasion : 2500§) (pT1b)
7. Resection margin : involved deep resection margin by carcinoma; safety margin : distal 1 mm, proximal 4 mm, anterior 1 mm, posterior 4 mm, deep 0 §
8. Lymphatic invasion : present
9. Venous invasion : not identified(N)
10. Perineural invasion : not identified(N)
11. Pre-existing adenoma : none
12. Microscopic ulcer : absent
13. Histologic heterogeneity: absent
Àú´Â ¾Æ·¡¿Í °°ÀÌ ¼³¸íÇÏ¿´½À´Ï´Ù.
³»½Ã°æ ½Ã¼ú ÈÄ ÃÖÁ¾ º´¸®°á°ú¸¦ È®ÀÎÇϱâ À§ÇÑ ¿Ü·¡ ¹æ¹®ÀÔ´Ï´Ù. ³»½Ã°æÀ¸·Î ÀýÁ¦ÇÑ Á¶Á÷¿¡ ´ëÇÑ º´¸®°á°ú¿¡¼´Â ¼¼Æ÷Çü, ±íÀÌ, ¹üÀ§, ¸²ÇÁ°ü/Ç÷°ü µîÀ» °üÂûÇÕ´Ï´Ù. ÃÖÁ¾ °á°ú¿¡¼ ¾ÏÀÌ Á¦1ÃþÀÎ Á¡¸·Ãþ¿¡ ±¹ÇѵǾî ÀÖÁö ¸øÇÏ°í, Á¡¸·ÇÏÃþ(À§º® 4Ãþ Áß Á¦ 2Ãþ)¿¡ Á¦¹ý ±í°Ô (2.5 mm Á¤µµ) ħÀ±µÇ¾î ÀÖ´Â °ÍÀ¸·Î ³ª¿Ô½À´Ï´Ù. º´¸®ÇÐÀû ±ÙÄ¡ ÀýÁ¦ ±âÁØÀ» ÃÊ°ú("beyond the criteria of the curative endoscopic resection")ÇÏ´Â »óȲÀÔ´Ï´Ù. °¡À̵å¶óÀο¡ µû¶ó ¼ö¼úÀ» ±ÇÇÕ´Ï´Ù ("additional curative surgery is recommended" - 2018³â Korean Practice Guideline Statement 4). ¾ÆÁ÷ ³í¶õÀº ÀÖÁö¸¸, ÀϹÝÀûÀ¸·Î º´¸®ÇÐÀû ±ÙÄ¡ ÀýÁ¦ ±âÁØÀ» ÃÊ°úÇÏ´Â °æ¿ì ¼ö¼úÀ» ¹ÞÀ¸¸é ¾à 10-20%Á¤µµ »ýÁ¸À²ÀÌ Çâ»óµË´Ï´Ù. ¼ö¼úÀ» ¹ÞÀ¸¸é 5³â »ýÁ¸À²ÀÌ 90%, ¼ö¼úÀ» ¹ÞÁö ¾ÊÀ¸¸é 5³â »ýÁ¸À²ÀÌ 80% Á¤µµ·Î »ý°¢Çϸé Å©°Ô Ʋ¸®Áö ¾Ê½À´Ï´Ù.
»ï¼º¼¿ïº´¿ø ÀÚ·áÀÔ´Ï´Ù. (Kim. Br J Surg 2015)
ÀϺ» ÀÚ·áÀÔ´Ï´Ù. (Hatta W. J Gastroenterol 2016)
¹°·Ð ¼ö¼úÀº ¼ö¼úÀÔ´Ï´Ù. ¼ö¼ú¿¡ µû¸¥ ÇÕº´Áõ°ú ¼ö¼ú ÈÄ »îÀÇ Áú ÀúÇϵµ ÇÔ²² °í·ÁÇØ¾ß ÇÕ´Ï´Ù. Àü½Å¸¶ÃëÀÇ À§Çèµµ ¹«½ÃÇÒ ¼ö ¾ø½À´Ï´Ù. µû¶ó¼ ¼ö¼úÇÏÁö ¾ÊÀ¸¸é À§¾Ï Àç¹ß·üÀÌ ¾î¶»°Ô µÇ´ÂÁö ±Ã±ÝÇÏ½Ç °ÍÀÔ´Ï´Ù.
ÀϺ» ÀÚ·á(Am J Gastroenterol 2017)¿¡ ÀÇÇϸé À§¾Ï ³»½Ã°æ Ä¡·á ÈÄ ºÒ¿ÏÀü ÀýÁ¦¿¡¼ Àç¹ß·üÀ» ¿¹ÃøÇÏ´Â ÀÎÀÚ´Â ¾Æ·¡¿Í °°½À´Ï´Ù.
ÀÎÀÚ °¡ÁßÄ¡ Å©±â 3cm ÀÌ»ó 1 ±íÁö SM2 ÀÌ»ó 1 ¸²ÇÁ¼± ħÀ± 3 Ç÷°ü ħÀ± 1 ½ÉºÎ ÀýÁ¦º¯¿¬ ¾ç¼º 1
º´¸®°á°ú¿¡ µû¶ó Àç¹ßÀ§ÇèÀ» Æò°¡ÇÕ´Ï´Ù. 0-1Á¡Àº ÀúÀ§Çè, 2-4Á¡Àº ÁßÀ§Çè, 5-7Á¡Àº °íÀ§ÇèÀÔ´Ï´Ù. ȯÀÚºÐÀº 5Á¡À¸·Î °íÀ§Çè¿¡ ÇØ´çÇÕ´Ï´Ù.
°°Àº ÀϺ» ÀÚ·á(Am J Gastroenterol 2017)¿¡¼ ÀúÀ§Çè, ÁßÀ§Çè, °íÀ§Çè ȯÀÚ°¡ ¼ö¼úÀ» ¹ÞÁö ¾Ê¾ÒÀ» ¶§ À§¾ÏÀ¸·Î »ç¸ÁÇÒ È®·üÀº ¾Æ·¡ ±×¸²°ú °°½À´Ï´Ù.
ÀúÈñ´Â ÃæºÐÈ÷ ¼³¸íÇÏ°í ȯÀÚÀÇ ÀÇ°ßÀ» Á¸ÁßÇÑ´Ù´Â ÀÔÀåÀÔ´Ï´Ù. ÀÌ·± °æ¿ì´Â º¸Åë »ý°¢ÇÒ ½Ã°£À» µå¸®°í ÀÖ½À´Ï´Ù. ÀÏ´Ü ¿Ü°ú ¼±»ý´ÔÀ» ¸¸³ª¼ »ó´ãÇϽʽÿÀ. Ȥ½Ã ¼ö¼úÀ» ÇÏÁö ¾Ê±â·Î °áÁ¤ÇϽŴٸé 1ÁÖÀÏ ÈÄ ³»°ú ¿Ü·¡µµ Àâ¾Æ³õ¾ÒÀ¸´Ï ´Ù½Ã ¹æ¹®ÇØ Áֽñ⠹ٶø´Ï´Ù. Àǹ«±â·Ïµµ ¿ì¸®¸»·Î ½á µÎ¾ú½À´Ï´Ù. º¹»çÇؼ °¡Á·°£¿¡ Àо½Ã±â ¹Ù¶ø´Ï´Ù.
°èȹ 1: Àǹ«±â·Ï º¹»ç
°èȹ 2: ¿Ü°ú ÀÇ·Ú
°èȹ 3: 1ÁÖÀÏ ÈÄ ³»°ú ¿Ü·¡ (Ȥ½Ã ¼ö¼úÀ» ÇÏÁö ¾Ê±â·Î °áÁ¤ÇÏ½Ã¸é ´Ù½Ã ¿À¼Å¼ »ó´ãÇØ Áֽñ⠹ٶø´Ï´Ù.)
¾Æ·¡´Â ½ÇÁ¦ Àǹ«±â·ÏÀÔ´Ï´Ù.
© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng. (2019-10-26)